USD
$0.00
(0.00%
)At Close (As of Oct 24, 2025)
$31.63M
Market Cap
-
P/E Ratio
-1.04
EPS
$1.32
52 Week High
$0.28
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $4.3M |
| Total Revenue | $54M |
| Cost Of Revenue | $50M |
| Costof Goods And Services Sold | $50M |
| Operating Income | -$16M |
| Selling General And Administrative | $12M |
| Research And Development | $533K |
| Operating Expenses | $20M |
| Investment Income Net | - |
| Net Interest Income | -$606K |
| Interest Income | $406K |
| Interest Expense | $1M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $1.2M |
| Income Before Tax | -$16M |
| Income Tax Expense | $6.2M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$16M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$15M |
| Ebitda | -$14M |
| Net Income | -$16M |
| Field | Value (USD) |
|---|---|
| Total Assets | $54M |
| Total Current Assets | $25M |
| Cash And Cash Equivalents At Carrying Value | $315K |
| Cash And Short Term Investments | $315K |
| Inventory | $4.4M |
| Current Net Receivables | $16M |
| Total Non Current Assets | $29M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $7.7M |
| Intangible Assets Excluding Goodwill | $7.7M |
| Goodwill | $50K |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $21K |
| Other Current Assets | $4.9M |
| Other Non Current Assets | - |
| Total Liabilities | $30M |
| Total Current Liabilities | $26M |
| Current Accounts Payable | $11M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $9.8M |
| Total Non Current Liabilities | $4M |
| Capital Lease Obligations | $710K |
| Long Term Debt | $1.6M |
| Current Long Term Debt | $9.6M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $12M |
| Other Current Liabilities | $4.8M |
| Other Non Current Liabilities | $2M |
| Total Shareholder Equity | $25M |
| Treasury Stock | - |
| Retained Earnings | -$114M |
| Common Stock | $24K |
| Common Stock Shares Outstanding | $19M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$7.7M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $1.2M |
| Capital Expenditures | $418K |
| Change In Receivables | - |
| Change In Inventory | $146K |
| Profit Loss | - |
| Cashflow From Investment | -$798K |
| Cashflow From Financing | $5M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | $6.2M |
| Dividend Payout Common Stock | $6.2M |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$100K |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$16M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $4.3M |
| Total Revenue | $54M |
| Cost Of Revenue | $50M |
| Costof Goods And Services Sold | $50M |
| Operating Income | -$16M |
| Selling General And Administrative | $12M |
| Research And Development | $533K |
| Operating Expenses | $20M |
| Investment Income Net | - |
| Net Interest Income | -$606K |
| Interest Income | $406K |
| Interest Expense | $1M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $1.2M |
| Income Before Tax | -$16M |
| Income Tax Expense | $6.2M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$16M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$15M |
| Ebitda | -$14M |
| Net Income | -$16M |
Sector: HEALTHCARE
Industry: MEDICAL DISTRIBUTION
Cosmos Health Inc. is a vertically integrated pharmaceutical company headquartered in Chicago, Illinois, dedicated to the development and distribution of a diverse array of pharmaceutical products and healthcare solutions. By leveraging a robust supply chain, the company enhances accessibility to innovative medicines while adhering to rigorous quality and regulatory standards. With a strategic focus on portfolio expansion and market growth, Cosmos Health aims to solidify its role as a significant participant in the global healthcare landscape. The company's commitment to forming strategic partnerships and investing in emerging markets underscores its mission to improve patient outcomes and foster sustainable growth.